首页> 外文期刊>European journal of drug metabolism and pharmacokinetics >Molecular docking to understand the metabolic behavior of GNF-351 by CYP3A4 and its potential drug-drug interaction with ketoconazole
【24h】

Molecular docking to understand the metabolic behavior of GNF-351 by CYP3A4 and its potential drug-drug interaction with ketoconazole

机译:分子对接了解CYP3A4对GNF-351的代谢行为及其与酮康唑的潜在药物相互作用

获取原文
获取原文并翻译 | 示例
       

摘要

GNF-351 is a candidate drug used to treat some diseases through antagonizing aryl hydrocarbon receptor. In the present study, molecular docking method was employed to understand the interaction between ketoconazole and GNF-351. The structure of cytochrome P450 (CYP) 3A4 was obtained from protein data bank, and 2-dimensional structure of GNF-351 with standard bond lengths and angles was drawn using chemdraw software. 30 possible binding orientations was generated and docked into the X-ray crystallographic structure of human CYP3A4. The predicted binding mode of GNF-351 into CYP3A4 appeared to adopt an orientation with interactions between their flat aromatic rings and Phe 302 and Phe 304. The comparison for the binding of GNF-351 and ketoconazole into the activity cavity indicated that they exhibited similar distance towards heme, indicating the potential interaction between GNF-351 and ketoconazole. These data remind us the necessary monitoring when future utilization between GNF-351 and ketoconazole.
机译:GNF-351是一种通过拮抗芳烃受体来治疗某些疾病的候选药物。在本研究中,分子对接方法被用来了解酮康唑和GNF-351之间的相互作用。从蛋白质数据库获得了细胞色素P450(CYP)3A4的结构,并使用chemdraw软件绘制了具有标准键长和角的GNF-351二维结构。产生了30种可能的结合方向,并将其对接至人CYP3A4的X射线晶体结构中。 GNF-351与CYP3A4的预测结合模式似乎采用了一个定向,且其平的芳香环与Phe 302和Phe 304之间发生了相互作用。比较了GNF-351和ketoconazole进入活动腔的结合,表明它们表现出相似的距离趋向于血红素,表明GNF-351与酮康唑之间存在潜在的相互作用。这些数据提醒我们在将来使用GNF-351和酮康唑时需要进行必要的监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号